Ryan D Maynard Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ryan D Maynard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ryan D Maynard. Ryan D Maynard is EVP & CFO in RIGEL PHARMACEUTICALS INC ($RIGL) and VP, CFO in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in Lion Biotechnologies, Inc. ($LBIO).
Latest Insider Trading Transactions of Ryan D Maynard
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2015 | LBIO | Lion Biotechnologi ... | Maynard Ryan D | Director | Option Exercise | A | 7.45 | 50,000 | 372,500 | 50,000 | |
| Jan 28 2015 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 2.14 | 175,000 | 374,500 | 175,000 | |
| Mar 03 2014 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 3.59 | 125,000 | 448,750 | 125,000 | |
| Jan 31 2013 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 6.51 | 150,000 | 976,500 | 150,000 | |
| Sep 14 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | M | 6.49 | 23,302 | 151,230 | 73,300 | |
| Sep 14 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.67 | 23,302 | 248,560 | 0 | 23.3 K to 0 (-100.00 %) |
| Sep 14 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Buy | M | 6.49 | 23,302 | 151,230 | 23,302 | 0 to 23.3 K |
| Sep 11 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | M | 6.49 | 17,586 | 114,133 | 96,602 | |
| Sep 11 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | M | 6.49 | 34,112 | 221,387 | 114,188 | |
| Sep 11 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.52 | 17,586 | 184,927 | 0 | 17.6 K to 0 (-100.00 %) |
| Sep 11 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Buy | M | 6.49 | 17,586 | 114,133 | 17,586 | 0 to 17.6 K |
| Sep 11 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.55 | 34,112 | 359,960 | 0 | 34.1 K to 0 (-100.00 %) |
| Sep 11 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Buy | M | 6.49 | 34,112 | 221,387 | 34,112 | 0 to 34.1 K |
| Aug 09 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | M | 6.49 | 1,700 | 11,033 | 148,300 | |
| Aug 09 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.63 | 300 | 3,188 | 0 | 300 to 0 (-100.00 %) |
| Aug 09 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.62 | 600 | 6,372 | 300 | 900 to 300 (-66.67 %) |
| Aug 09 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.61 | 100 | 1,061 | 900 | 1,000 to 900 (-10.00 %) |
| Aug 09 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.60 | 700 | 7,420 | 1,000 | 1.7 K to 1,000 (-41.18 %) |
| Aug 09 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Buy | M | 6.49 | 1,700 | 11,033 | 1,700 | 0 to 1.7 K |
| Jan 27 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 8.15 | 150,000 | 1,222,500 | 150,000 | |
| Feb 03 2011 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 6.73 | 65,000 | 437,450 | 65,000 | |
| Jun 01 2010 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 6.55 | 120,000 | 786,000 | 120,000 | |
| Jan 25 2010 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | VP, CFO | Option Exercise | A | 9.62 | 85,000 | 817,700 | 85,000 | |
| Mar 31 2009 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | VP, CFO | Option Exercise | A | 6.49 | 150,000 | 973,500 | 150,000 | |
| Feb 04 2008 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | VP, CFO | Option Exercise | A | 26.45 | 75,000 | 1,983,750 | 75,000 | |
| Feb 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | VP, CFO | Option Exercise | A | 11.73 | 106,911 | 1,254,066 | 106,911 |
Page: 1